Literature DB >> 2666662

Acupuncture prophylaxis of cancer chemotherapy-induced sickness.

J W Dundee1, R G Ghaly, K T Fitzpatrick, W P Abram, G A Lynch.   

Abstract

In a multi-facet study we evaluated the efficacy of P6 electroacupuncture (10 Hz applied for 5 min) as an antiemetic in patients receiving a variety of cancer chemotherapy drugs. The study involved 130 (15 in an open pilot study, 10 in a randomized placebo controlled crossover study and 105 in a definitive study) patients who had a history of distressing sickness after previous treatment, and who, on the basis of a previous survey, would be expected to have a 96% chance of this with subsequent therapy. Sickness was either completely absent or reduced considerably in 97% of patients and no side effects were encountered. The limited crossover study, using a 'dummy' acupuncture (ACP) point showed that the beneficial effects were limited to the P6 point. Logistic and ethical considerations excluded the possibility of carrying out a larger placebo-controlled study. While in our hands P6 ACP was an effective antiemetic in patients having cancer chemotherapy, because of the time involved and the brevity of the action (8 h) an alternative approach to electro-ACP is required before this technique is adopted clinically.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2666662      PMCID: PMC1292129          DOI: 10.1177/014107688908200508

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  26 in total

1.  Antiemetic studies: a methodological discussion.

Authors:  I N Olver; R M Simon; J Aisner
Journal:  Cancer Treat Rep       Date:  1986-05

2.  Antiemetic studies with traditional Chinese acupuncture. A comparison of manual needling with electrical stimulation and commonly used antiemetics.

Authors:  R G Ghaly; K T Fitzpatrick; J W Dundee
Journal:  Anaesthesia       Date:  1987-10       Impact factor: 6.955

3.  Acupuncture to prevent cisplatin-associated vomiting.

Authors:  J W Dundee; R G Ghaly; K T Fitzpatrick; G A Lynch; W P Abram
Journal:  Lancet       Date:  1987-05-09       Impact factor: 79.321

4.  Controlled trial of acupuncture for disabling breathlessness.

Authors:  K Jobst; J H Chen; K McPherson; J Arrowsmith; V Brown; J Efthimiou; H J Fletcher; G Maciocia; P Mole; K Shifrin
Journal:  Lancet       Date:  1986 Dec 20-27       Impact factor: 79.321

Review 5.  The control of cancer chemotherapy-induced nausea and vomiting.

Authors:  L J Dodds
Journal:  J Clin Hosp Pharm       Date:  1985-06

6.  Acupuncture as an antiemetic.

Authors:  J W Dundee; K R Milligan
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-09

7.  Traditional Chinese acupuncture as an antiemetic.

Authors:  W M Weightman; M Zacharias; P Herbison
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-28

8.  Antiemetic efficacy of high-dose dexamethasone versus placebo in patients receiving cisplatin-based chemotherapy: a randomized double-blind controlled clinical trial.

Authors:  J T D'Olimpio; F Camacho; P Chandra; M Lesser; M Maldonado; D Wollner; P H Wiernik
Journal:  J Clin Oncol       Date:  1985-08       Impact factor: 44.544

9.  Psychological impact of adjuvant chemotherapy in the first two years after mastectomy.

Authors:  A V Hughson; A F Cooper; C S McArdle; D C Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-15

10.  An effective five-drug antiemetic combination for prevention of chemotherapy-related nausea and vomiting. Experience in eighty-four patients.

Authors:  J F Kessler; D S Alberts; P M Plezia; V Wilson; J Chase; M Aapro; E A Surwit
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

View more
  29 in total

1.  Proceedings of the British Pharmacological Society, British Pharmacology Section. 18-20 April 1990, Sheffield. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

2.  Proceedings of the British Pharmacological Society. 12-14 September 1990, Belfast.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

3.  Acupuncture as a complementary therapy in chemotherapy-induced nausea and vomiting.

Authors:  Ling Ma
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-04

Review 4.  Positive evidence for P6 acupuncture antiemesis.

Authors:  J W Dundee; C McMillan
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

5.  Qigong stress reduction in hospital staff.

Authors:  Jay M Griffith; Joseph P Hasley; Hong Liu; Daniel G Severn; Latoya H Conner; Lawrence E Adler
Journal:  J Altern Complement Med       Date:  2008-10       Impact factor: 2.579

6.  Teaching residents about complementary and alternative medicine in the United States.

Authors:  F B Milan; C Landau; D R Murphy; J J Balletto; T Sztykowski; J A Hart; C H Rybeck; M G Cyr
Journal:  J Gen Intern Med       Date:  1998-08       Impact factor: 5.128

Review 7.  Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.

Authors:  Heather Greenlee; Melissa J DuPont-Reyes; Lynda G Balneaves; Linda E Carlson; Misha R Cohen; Gary Deng; Jillian A Johnson; Matthew Mumber; Dugald Seely; Suzanna M Zick; Lindsay M Boyce; Debu Tripathy
Journal:  CA Cancer J Clin       Date:  2017-04-24       Impact factor: 508.702

8.  Randomized double-blind study of the Reliefband as an adjunct to standard antiemetics in patients receiving moderately-high to highly emetogenic chemotherapy.

Authors:  Imad Treish; Stacy Shord; John Valgus; Donald Harvey; Jessica Nagy; Jennifer Stegal; Celeste Lindley
Journal:  Support Care Cancer       Date:  2003-06-27       Impact factor: 3.603

9.  Ineffectiveness of acupuncture and droperidol in preventing vomiting following strabismus repair in children.

Authors:  S M Yentis; B Bissonnette
Journal:  Can J Anaesth       Date:  1992-02       Impact factor: 5.063

10.  Safety and efficacy of acupuncture in children: a review of the evidence.

Authors:  Vanita Jindal; Adeline Ge; Patrick J Mansky
Journal:  J Pediatr Hematol Oncol       Date:  2008-06       Impact factor: 1.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.